Stay updated on MUKnineb: OPTIMUM Treatment Protocol Clinical Trial

Sign up to get notified when there's something new on the MUKnineb: OPTIMUM Treatment Protocol Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MUKnineb: OPTIMUM Treatment Protocol Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page’s related-topics area (e.g., MedlinePlus Genetics for multiple myeloma) was refreshed and the site footer revision/version updated from v3.5.2 to v3.5.3.
    Difference
    0.2%
    Check dated 2026-04-26T13:45:11.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision metadata updated: v3.5.2 added, v3.5.0 removed.
    Difference
    0.0%
    Check dated 2026-04-19T05:19:37.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Removed the study condition 'Multiple Myeloma' and related topics (MedlinePlus Genetics) from the page.
    Difference
    0.1%
    Check dated 2026-04-11T22:11:39.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T08:29:56.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page now includes related topics for Multiple Myeloma and MedlinePlus Genetics, and the revision note was updated from v3.4.2 to v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-06T19:01:19.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2, and some related-topic links were removed; the core study information and navigation remain unchanged.
    Difference
    0.2%
    Check dated 2026-02-13T12:39:30.000Z thumbnail image

Stay in the know with updates to MUKnineb: OPTIMUM Treatment Protocol Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MUKnineb: OPTIMUM Treatment Protocol Clinical Trial page.